Article Type
Article
Changed
Tue, 05/21/2019 - 12:13
Display Headline
The Science Behind Monoclonal Antibodies: What Neurologists Need to Know

Click Here to Read the Content. 

Topics in this content include:

  • Target-related and non-specific toxicity of therapeutic monoclonal antibodies (mAbs)
  • Research in antibody-based therapeutics
  • Differences between therapeutic mAbs and small-molecule therapies
USA-334-80408
Sponsor
This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporatio…
Publications
MDedge Neurology
Neurology Reviews
Sections
Medical Education Library
Supplements
Sponsor
This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporatio…
Sponsor
This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporatio…

Click Here to Read the Content. 

Topics in this content include:

  • Target-related and non-specific toxicity of therapeutic monoclonal antibodies (mAbs)
  • Research in antibody-based therapeutics
  • Differences between therapeutic mAbs and small-molecule therapies
USA-334-80408

Click Here to Read the Content. 

Topics in this content include:

  • Target-related and non-specific toxicity of therapeutic monoclonal antibodies (mAbs)
  • Research in antibody-based therapeutics
  • Differences between therapeutic mAbs and small-molecule therapies
USA-334-80408
Publications
MDedge Neurology
Neurology Reviews
Publications
MDedge Neurology
Neurology Reviews
Article Type
Article
Display Headline
The Science Behind Monoclonal Antibodies: What Neurologists Need to Know
Display Headline
The Science Behind Monoclonal Antibodies: What Neurologists Need to Know
Sections
Medical Education Library
Supplements
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Fri, 03/23/2018 - 13:45
Un-Gate On Date
Fri, 03/23/2018 - 13:45
Use ProPublica
Teaser Media